Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-400
Closed -$20K 11387
2014
Q2
$20K Sell
400
-2,200
-85% -$101K ﹤0.01% 8122
2014
Q1
$114K Hold
2,600
﹤0.01% 5830
2013
Q4
$90K Buy
2,600
+1,400
+117% +$52.4K ﹤0.01% 6194
2013
Q3
$49K Sell
1,200
-200
-14% -$7.53K ﹤0.01% 6907
2013
Q2
$50K Buy
+1,400
New +$46.7K ﹤0.01% 6754

Other funds holding CAVM

UBS's CAVM Position: Q3 2014 in Review

UBS reduced its Cavium, Inc. (CAVM) stake by 31% in Q3 2014, selling an estimated $1.52M and leaving 66,168 shares worth $3.29M. The position accounts for ﹤0.01% of the portfolio, ranked #2433.

UBS first reported a position in CAVM in Q2 2013 and has held it in 6 quarters since. The position peaked at $4.96M in Q2 2013. 201 funds tracked by Wall St. Rank hold CAVM as of Q3 2014.

  • UBS held 66,168 shares of Cavium, Inc. worth $3.29M as of Q3 2014.
  • UBS sold 30,087 Cavium, Inc. shares in Q3 2014, an estimated $1.52M.
  • Cavium, Inc. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2433 holding.
  • UBS first reported a position in Cavium, Inc. in Q2 2013 and has held it in 6 quarters since.
  • UBS's Cavium, Inc. position peaked at $4.96M in Q2 2013.
  • 201 funds tracked by Wall St. Rank held Cavium, Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.